Spain – Antineoplastic agents – Suministro sucesivo de diversos medicamentos para el tratamiento del mieloma múltiple para el Área Sanitaria de Ferrol
awardedServizo Galego de Saúde. Área Sanitaria de Ferrol · Q1500308J
Value
€1.5m
Published
17 Nov 2026
Deadline
—
Type
award · framework
33652100 · Medical equipment, pharmaceuticals & personal careES111
Description
Carfilzomib
Key facts
- Procedure
- neg-wo-call
- Framework agreement
- Yes — a framework or dynamic purchasing system, not a single contract
- Pre-award estimate
- €1.5m
- Regime
- publicSector
- Contract references
- Lote1Lote2Lote3Lote4Lote5Lote6
- Category
- supplies
Awarded suppliers
- AMGEN SA · A59363655 · ES511, ES
- Janssen-Cilag SA · A28925899 · ES300, ES
- Sanofi Aventis SA · A08163586 · ES511, ES
- PFIZER SLU · B28089225 · ES300, ES
Ground given for limiting competition
The buyer’s own stated reason for awarding without open competition, as published. Their assertion, not a finding.
technical
Derivado de acuerdo marco
What a subscription adds to this notice
- The documents — every attachment, with its text extracted and searchable
- Qualification — the notice scored against your company profile
- Tracking and alerts — a pipeline for your bids, and the matching notices by email
- The API and MCP — the same record in your own tools and your AI assistant
Provenance
- Source
- ted-eu
- Notice id
- 797799-2026
- First seen
- 17 Nov 2026
- Last updated
- 17 Nov 2026
Licence EU reuse — Commission Decision 2011/833/EU ↗
Source: TED — Tenders Electronic Daily (ted.europa.eu), © European Union, reused under Commission Decision 2011/833/EU.
View at source ↗
GET /api/v1/tenders/0ed926e7-72f5-4337-80d9-6d657d284750The source notice is authoritative — verify deadlines and documents there before bidding.